Long‐term efficacy and safety of adjunctive extended‐release oxcarbazepine (Oxtellar XR(®)) in adults with partial‐onset seizures

OBJECTIVE: To evaluate long‐term outcomes of adjunctive therapy with SPN‐804 (Oxtellar XR(®), Supernus Pharmaceuticals), an extended‐release tablet formulation of oxcarbazepine (OXC), in adults with refractory partial‐onset seizures. METHODS: After completing a 16‐week double‐blind, placebo‐controll...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, S. S., Johnson, J. K., Brittain, S. T., Baroldi, P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042072/
https://www.ncbi.nlm.nih.gov/pubmed/26248506
http://dx.doi.org/10.1111/ane.12467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5042072/
https://www.ncbi.nlm.nih.gov/pubmed/26248506
http://dx.doi.org/10.1111/ane.12467

Ejemplares similares